Abstract
Background There is concern that the PUFA composition of ready-to-use therapeutic food (RUTF) for treatment of severe acute malnutrition (SAM) is suboptimal for neurocognitive recovery.
Objective We tested the hypothesis that RUTF made with reduced amounts of linoleic acid, achieved using high oleic (HO) peanuts, with or without added DHA, improves cognition when compared to standard RUTF (S-RUTF).
Methods A triple-blind, randomized, controlled clinical feeding trial was conducted among children with uncomplicated SAM in Malawi with 3 types of RUTF; DHA-HO-RUTF, HO-RUTF and S-RUTF. The primary outcomes, measured in a subset of subjects, were the Malawi Developmental Assessment Tool (MDAT) global and 4 domain (gross motor, fine motor, language and social) z-scores and a modified Willatts problem solving assessment (PSA) intention score for 3 standardized problems, measured 6 months and immediately after completing RUTF therapy, respectively. Plasma fatty acid content, anthropometry and eye tracking were secondary outcomes. Comparisons were made between the novel PUFA RUTFs and S-RUTF.
Results Among the 2565 SAM children enrolled, global MDAT z-score was -0.69 ± 1.19 and - 0.88 ± 1.27 for children receiving DHA-HO-RUTF and S-RUTF, respectively (difference 0.19, 95% CI 0.01 to 0.38). The gross motor and social domains had higher z-scores among children receiving either DHA-HO-RUTF than S-RUTF. The PSA problem 3 scores did not differ by dietary group (Odds ratio 0.92, 95% CI 0.67 to 1.26 for DHA-HO-RUTF). After 4 weeks of treatment, plasma phospholipid EPA and α-linolenic acid were greater in children consuming DHA-HO-RUTF or HO-RUTF when compared to S-RUTF (for all 4 comparisons P values < 0.001), but only plasma DHA was greater in DHA-HO-RUTF than S-RUTF (P <0.001).
Conclusions Treatment of uncomplicated SAM with DHA-HO-RUTF resulted in an improved MDAT score, conferring a cognitive benefit six months after completing diet therapy. This treatment should be explored in operational settings.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT03094247
Funding Statement
Funding was generously provided by Unorthodox Philanthropy, Open Philanthropy and the Hickey Family Foundation. Wiley Companies supported the work with a donation of ingredients for one of the study foods.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The trial was approved by the Human Studies Committee of Washington University and the College of Medicine Research and Ethics Committee of the University of Malawi.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* considered as first authors
↵# considered as senior authors
Authors last names: Stephenson, Callaghan-Gillespie, Maleta, Nkhoma, George, Park, Lee, Humphries-Cuff, LaCombe, Wegner, Canfield, Brenna, Manary
Disclaimers: KS, MCG, KM, MN, MG, HGP, RL, IHC, DRW, JTB, RLC, RJSL, RC, MJM have no conflict of interest to declare. MJM is an associate editor of AJCN.
Sources of support: Funding was generously provided by Unorthodox Philanthropy and Open Philanthropy. Wiley Companies supported the work with a donation of ingredients for one of the study foods.
Data Share Statement: Data described in the manuscript, code book, and analytic code will be made available upon request pending application to the corresponding author and approval.
Trial registry: NCT03094247, clinicaltrials.gov
Data Availability
Data described in the manuscript, code book, and analytic code will be made available upon request pending application to the corresponding author and approval.
Abbreviations used
- ALA
- α-linolenic acid;
- DHA
- docosahexaenoic acid;
- DHA-HO-RUTF
- high oleic acid RUTF with added DHA;
- EPA
- eicosapentaenoic acid;
- HAZ
- height-for-age z-score;
- HO-RUTF
- high oleic acid RUTF;
- LA
- linoleic acid;
- MDAT
- Malawi Developmental Assessment Tool;
- MUAC
- mid-upper arm circumference;
- PSA
- problems solving assessment;
- PUFA
- polyunsaturated fatty acid;
- RUTF
- ready-to-use therapeutic food;
- SAM
- severe acute malnutrition;
- S-RUTF
- standard RUTF;
- WHZ
- weight-for-height z-score
